Guidelines on valvular heart disease
240acut-offvalueof0.6cm2/m2BSAishelpful,inparticularinpatientswitheitherunusuallysmallorlargeBSA.
SevereASisunlikelyifcardiacoutputisnormal,andthereisameanpressuregradient,50mmHg.Inthepresenceoflow ow,usuallyduetodepressedLVfunction,lowpressuregradientsmaybeencounteredinpatientswithsevereAS.Assoonasmeangradientis,40mmHg,evenasmallvalveareadoesnotde nitelycon rmsevereASsincemild-to-moderatelydiseasedvalvesmaynotopenfully,resultingina‘functionallysmallvalvearea’(pseudosevereAS).67
Stressechocardiographyusinglow-dosedobutaminemaybehelpfulinthissettingtodistinguishtrulysevereASfromtherarecasesofpseudosevereAS.27TrulysevereASshowsonlysmallchangesinvalvearea(increase,0.2cm2)withincreasing owratebutsigni cantincreaseingradients(maximumvalueofmeangradient.50mmHg),whereaspseudosevereASshowsmarkedincreaseinvalveareabutonlyminorchangesingradients.27,68Inaddition,thistestmaydetectthepresenceofcontractilereserve(increase.20%ofstrokevolumeduringlow-dosedobuta-minetest),whichhasprognosticimplications.27,68
Exercisestressechocardiographyhasbeenproposedforriskstrati cationinasymptomaticsevereAS25butmoredataarenecessarytodetermineitsrole.
Echocardiographicevaluationwillidentifycoexistentvalvularlesionsincludingmitralannularcalci cationindegenerativediseaseandrheumaticmitralvalvedisease,aswellasasymmetricdynamicsubvalvularobstructionespeciallyinelderlywomen.
TEEisrarelyneeded;however,itmayprovideimagesthataregoodenoughtoallowvalveplanimetryandthisisusefulwhentransthoracicvisualizationispoorandlea etsonlymoderatelycalci ed.TEEwillalsoprovideadditionalevalu-ationofothermitralvalveabnormalities.
ExercisetestingiscontraindicatedinsymptomaticpatientswithASbutisusefulforunmaskingsymptomsandintheriskstrati cationofasymptomaticpatientswithsevereAS.21,22Insuchcases,itissafe,provideditisper-formedunderthesupervisionofanexperiencedphysician,withsymptoms,changesinbloodpressure,andECGcloselymonitored.Incurrentpractice,stresstestsareunder-usedinpatientswithasymptomaticAS.3
CTandMRIcouldimproveassessmentoftheascendingaorta,ifrequired.PreliminarydatasuggestthatmultisliceCTmaybeusefulinquantifyingvalvecalci cation,whichaidsinassessingprognosis,28aswellasinmeasuringvalvearea.69However,moredataarerequiredtodeterminethefullroleofmultisliceCT.
Natriureticpeptideshavebeenshowninpreliminarystudiestopredictsymptom-freesurvivalinAS.30However,moredataarerequiredbeforerecommendingtheirserialmeasurementtoidentifyoptimaltimingofsurgery.
RetrogradeLVcatheterizationtoassesstheseverityofASisseldomneededandshouldonlybeusedwithcaution,asitisnotwithoutrisk.32
Naturalhistory
Calci cASisachronicprogressivedisease.Duringalonglatentperiod,patientsremainasymptomatic.70–72However,itshouldbeemphasizedthatdurationoftheasymptomaticphasevarieswidelyamongindividuals.
ESCGuidelines
Suddencardiacdeathisafrequentcauseofdeathinsymp-tomaticpatientsbutappearstoberareintheasymptomatic( 1%peryear).70–72Reportedaveragesymptom-freesurvi-valat2yearsrangesfrom20tomorethan50%.21,22,70–72Thelowernumbersmustbeviewedwithcautionsincesomepatientsinthesestudiesunderwentsurgerywithoutsymptoms.Finally,ithasbeenspeculatedthatmyocardial brosisandsevereLVhypertrophy,whichmaynotberevers-ibleafterdelayedsurgery,couldprecludeanoptimalpost-operativelong-termoutcome.However,thereare,sofar,nodatatocon rmthishypothesis.
PredictorsoftheprogressionofASand,therefore,ofpooroutcomeinasymptomaticpatientshaverecentlybeenidenti ed.Theyare:
.Clinical:olderage,presenceofatheroscleroticriskfactors.65,66
.
Echocardiography:valvecalci cation,peakaorticjetvel-ocity,LVEF,71,72haemodynamicprogression,71andincreaseingradientwithexercise.25Thecombinationofamarkedlycalci edvalvewitharapidincreaseinvelocityof 0.3m/swithin1yearhasbeenshowntoidentifyahigh-riskgroupofpatients( 80%deathorrequirementofsurgerywithin2years71).
.
Exercisetesting:symptomdevelopmentonexercisetestinginphysicallyactivepatients,particularlythoseyoungerthan70years,predictsaveryhighlikelihoodofsymptomdevelopmentwithin12months.Recentdatademonstratesalowerpositivepredictivevalueforabnor-malbloodpressureresponse,andevenmoresoforST-segmentdepression,thansymptomsforpooroutcome.22
Assoonassymptomsoccur,theprognosisisdismalandmortalityhasbeenreportedtobequitesigni cantevenwithinmonthsofsymptomonset,73whichisoftennotpromptlyreportedbypatients.
Resultsofintervention
Aorticvalvereplacementisthede nitivetherapyforsevereAS.Incontemporaryseries,operativemortalityofisolatedaorticvalvereplacementis 3–5%inpatientsbelow70yearsand5–15%inolderadults(Table5).3,51,52Thefol-lowingfactorsincreasetheriskofoperativemortality:olderage,associatedcomorbidities,femalegender,higherfunctionalclass,emergencyoperation,LVdysfunction,pul-monaryhypertension,coexistingcoronarydisease,andpre-viousbypassorvalvesurgery.Aftersuccessfulvalvereplacement,long-termsurvivalratesareclosetothoseexpectedinthecontrolpopulation,symptomsarelessmarked,andqualityoflifeisgreatlyimproved.74Riskfactorsforlatedeathincludeage,comorbidities,severefunctionalcondition,LVdysfunction,ventriculararrhyth-mias,anduntreatedcoexistingcoronaryarterydisease.Inaddition,poorpostoperativeoutcomemayresultfromprosthesis-relatedcomplicationsandsub-optimalprostheticvalvehaemodynamicperformance.75
Balloonvalvuloplastyplaysanimportantroleinthepae-diatricpopulationbutaverylimitedroleinadultsbecauseitsef cacyislow,complicationrateishigh(.10%),andrestenosisandclinicaldeteriorationoccurwithin6–12monthsinmostpatients,resultinginamid-termandlong-termoutcomesimilartonaturalhistory.76Preliminary
Guidelines for the Management of Patients 年 With Valvular Heart Disease (美国) 美国) 2007年:ESC Guidelines on the Management of Valvular Heart 年 Disease...
Guidelines for the Management of Patients 年 With Valvular Heart Disease (美国) 美国) 2007年:ESC Guidelines on the Management of Valvular Heart 年 Disease...
2006年: ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease (美国) ? 2007年:ESC Guidelines on the Management of Valvular Heart...
VALVULAR HEART DISEASE 52页 7下载券 Valvular Heart Disease 暂无评价 87页 1下载券 2007:ESC:Guidelines ... 39页 1下载券 A403-A418 Valvular Hea... 16...
No part of the ESC Guidelines may be translated or reproduced in any form..., Working Group on Thrombosis, Working Group on Valvular Heart Disease. ...
10.1093/eurheartj/ehr218 ESC GUIDELINES ESC Guidelines on the management ...Valvular Heart Disease, Cardiovascular Pharmacology and Drug Therapy, Acute Cardiac...
Guidelines on the prevention, diagnosis, and ...(ESCMID) and the International Society of ...on valvular heart disease: focused update on ...
10.1093/eurheartj/ehu281 ESC GUIDELINES 2014 ESC Guidelines on the ...and Cardiac Computed Tomography, Peripheral Circulation, Valvular Heart Disease....
European Heart Journal doi:10.1093/eurheartj/ehs104 ESC GUIDELINES ESC ...Valvular Heart Disease Councils: Cardiovascular Imaging, Cardiovascular Nursing and...
Valvular Heart Disease Councils: Cardiovascular Imaging, Cardiovascular Nursing and...No part of the ESC Guidelines may be translated or reproduced in any form...
热门文档